ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlaudraff, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlaudraff, K.
Related Collections
Right arrow Valve disease

Ann Thorac Surg 2006;81:56
© 2006 The Society of Thoracic Surgeons


Original article: Cardiovascular

Invited commentary

Kirsten Schlaudraff, MD

Clinic for Cardiovascular Surgery, University Hospital, Rue du Bugnon 47, Lausanne, CH 1011 Switzerland

(Email: kirsten.schlaudraff@gmx.ch).

The first 20% of the full text of this article appears below.

The fact that none of the heart valve prostheses that are currently available are ideally suited for any clinical situation is well known. Looking for new materials more recently chemically-altered polyurethane (PU) has been used in artificial heart valve design, whereas the new concept of tissue-engineering has enhanced the prospects toward an ideal cardiac valve replacement. PU scaffolds are already used as vascular biomaterials due to their mechanical properties and good hemocompatibility [1]. Several studies with vascular grafts demonstrate that these are encapsulated by . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2006 by The Society of Thoracic Surgeons.